MEDICUS PHARMA LTD. Operating Lease, Liability, Current
MEDICUS PHARMA LTD. (MDCX) had Operating Lease, Liability, Current of $137.33 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-12
- 2026-06-30: Operating Lease, Liability, Current $137.33K.
- 2026-03-31: Operating Lease, Liability, Current $145.46K.
- 2025-12-31: Operating Lease, Liability, Current $145.46K.
- 2025-09-30: Operating Lease, Liability, Current $141.07K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $137.33K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $145.46K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $145.46K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $141.07K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $124.40K 10-Q · filed 2025-08-11 |
| 2025-03-31 | $120.30K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $116.32K 10-K · filed 2026-03-25 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |